Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$27.50 -1.07 (-3.75%)
As of: Oct 23, 2026 · 2:24 PM EDT

Amylyx Pharmaceuticals (AMLX) Net Preferred Shares Issued and Repurchased (2021)

Updated

Analysis

Amylyx Pharmaceuticals (AMLX) Net Preferred Shares Issued and Repurchased (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,129.53 Bn 1,098.12 Bn 19.71 Bn -
2 Johnson & Johnson 634.39 Bn 554.25 Bn 17.30 Bn -
3 AbbVie 505.42 Bn 478.53 Bn 12.70 Bn -
4 Merck 358.13 Bn 312.50 Bn 12.21 Bn -
5 Novartis Ag 289.84 Bn 253.83 Bn 11.24 Bn -
6 Astrazeneca 265.39 Bn 239.08 Bn 12.86 Bn -
7 Amgen 238.10 Bn 193.50 Bn 7.24 Bn -
8 Gilead Sciences 194.55 Bn 168.75 Bn 6.22 Bn -
9 Pfizer 171.08 Bn 117.73 Bn 10.94 Bn -
10 Amylyx Pharmaceuticals 3.06 Bn 1.86 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 209,000.00
Sep 30, 2021 132.72 Mn
API Access

Amylyx Pharmaceuticals Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=AMLX&period=max&api_key=YOUR_API_KEY